Inventor · disambiguated record
Howard S. Roth
Also filed as: ROTH HOWARD S
16 granted patents·85 citations·filing 2013–2022
92Inventor score
Top patents by PatentIndex Score
16 records- 0197US11485708B2Compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·9 cites·21 claims
- 0296US11691985B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2021·Granted Jul 4, 2023·4 cites·20 claims
- 0396US11059834B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·10 cites·18 claims
- 0496US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 0595US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 0695US9663482B2Substituted piperazinyl acetohydrazide procaspase-activating compoundsUNIV ILLINOIS·Filed 2016·Granted May 30, 2017·8 cites·18 claims
- 0793US10392405B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2018·Granted Aug 27, 2019·13 cites·46 claims
- 0893US9249116B2Enzyme-activating compounds and compositionsUNIV ILLINOIS·Filed 2013·Granted Feb 2, 2016·10 cites·19 claims
- 0987US11427541B2Salt forms of a complement component C5A receptorCHEMOCENTRYX INC·Filed 2020·Granted Aug 30, 2022·2 cites·32 claims
- 1086US9399035B2Procaspase 3 activation by combination therapyHERGENROTHER PAUL J·Filed 2013·Granted Jul 26, 2016·8 cites·5 claims
- 1184US10888560B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2018·Granted Jan 12, 2021·1 cites·10 claims
- 1274US11833147B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2021·Granted Dec 5, 2023·0 cites·6 claims
- 1374US10085977B2Procaspase 3 activation by combination therapyUNIV ILLINOIS·Filed 2016·Granted Oct 2, 2018·1 cites·18 claims
- 1460US12018016B2Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Jun 25, 2024·0 cites·59 claims
- 1557US12012403B2Aryl sulfonyl compounds as CCR6 inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Jun 18, 2024·0 cites·21 claims
- 1655US11872217B2Indanes as PD-L1 inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Jan 16, 2024·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Howard S. Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →